Episode 24. ASCO/EHA 2023 Special: Updates on CAR T-cell Therapy in Myeloma
Blood Cancer Talks
00:00
The Signal of Second Primary Malignancies in Parkinson's Disease
The typical Parkinson's disease treatment doesn't seem to work here, right? Like the cinema at, for example, Carbidobally, Vodopa has those been tried in these patients? Yeah, so our experience has been that those have not worked. And I believe that was the experience that some of the other patients as well in Cartitude 1. So it seems to be somewhat different mechanistically. Right, so while we do not yet have a really long term follow up, you know, but both with both Karma 3 and Cartitude 4,. There is still in supplement in both trials have shown some cases of MDS AML in the CAR-T arm, whereas none in
Transcript
Play full episode
